Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Anjo Veerman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Physiology

Chemicals & Drugs

Living Beings

Infant

Anatomy

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hennipman Bernadette; de Vries Esther; Bökkerink Jos P M; Ball Lynn M; Veerman Anjo J P
Intrathecal vincristine: 3 fatal cases and a review of the literature.
Sitaresmi Mei Neni; Mostert Saskia; Purwanto Ignatius; Gundy Chad M; Sutaryo; Veerman Anjo J P
Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions.
Buizer Annemieke I; de Sonneville Leo M J; Veerman Anjo J P
Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Anjo Veerman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hennipman Bernadette; de Vries Esther; Bökkerink Jos P M; Ball Lynn M; Veerman Anjo J P
Intrathecal vincristine: 3 fatal cases and a review of the literature.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2009;31(11):816-9.
2009: Sitaresmi Mei Neni; Mostert Saskia; Purwanto Ignatius; Gundy Chad M; Sutaryo; Veerman Anjo J P
Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions.
Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses 2009;26(4):198-207.
2009: Buizer Annemieke I; de Sonneville Leo M J; Veerman Anjo J P
Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: a critical review of the literature.
Pediatric blood & cancer 2009;52(4):447-54.
2009: Mostert Saskia; Sitaresmi Mei N; Gundy Chad M; Sutaryo; Veerman Anjo J P
Does aid reach the poor? Experiences of a childhood leukaemia outreach-programme.
European journal of cancer (Oxford, England : 1990) 2009;45(3):414-9.
2008: Sitaresmi Mei Neni; Mostert Saskia; Gundy Chad M; Sutaryo; Veerman Anjo J P
Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia.
Pediatric blood & cancer 2008;51(6):732-6.
2008: van Grotel Martine; van den Heuvel-Eibrink Marry M; van Wering Elisabeth R; van Noesel Max M; Kamps Willem A; Veerman Anjo J P; Pieters Rob; Meijerink Jules P P
CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia.
Pediatric blood & cancer 2008;51(6):737-40.
2008: Mostert Saskia; Sitaresmi Mei N; Gundy Chad M; Sutaryo; Veerman Anjo J P
Parental experiences of childhood leukemia treatment in indonesia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2008;30(10):738-43.
2008: Appel I M; Kazemier K M; Boos J; Lanvers C; Huijmans J; Veerman A J P; van Wering E; den Boer M L; Pieters R
Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(9):1665-79.
2008: Haarman E G; Kaspers G J L; Pieters R; Rottier M M A; Veerman A J P
Circumvention of glucocorticoid resistance in childhood leukemia.
Leukemia research 2008;32(9):1417-23.
2008: Jansen Nathalie C A J; Kingma Annette; Schuitema Arnout; Bouma Anke; Veerman Anjo J P; Kamps Willem A
Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3025-30.
2008: Mostert Saskia; Sitaresmi Mei N; Gundy Chad M; Veerman Anjo J P
Attitude of health-care providers toward childhood leukemia patients with different socio-economic status.
Pediatric blood & cancer 2008;50(5):1001-5.
2008: van Grotel M; Meijerink J P P; van Wering E R; Langerak A W; Beverloo H B; Buijs-Gladdines J G C A M; Burger N B; Passier M; van Lieshout E M; Kamps W A; Veerman A J P; van Noesel M M; Pieters R
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(1):124-31.
2008: Giovannetti Elisa; Ugrasena Dewa G; Supriyadi Eddy; Vroling Laura; Azzarello Antonino; de Lange Desiree; Peters Godefridus J; Veerman Anjo J P; Cloos Jacqueline
Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.
Leukemia research 2008;32(1):19-24.
2007: Te Poele Esther M; de Bont Eveline S J M; Marike Boezen H; Revesz Tom; Bökkerink Jos P M; Beishuizen Auke; Nijhuis Ilse J M; Oude Nijhuis Claudi S M; Veerman Anjo J P; Kamps Willem A
Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?
European journal of cancer (Oxford, England : 1990) 2007;43(17):2532-6.
2007: Haupt Riccardo; Spinetta John J; Ban Irina; Barr Ronald D; Beck Joern D; Byrne Julianne; Calaminus Gabriele; Coenen Eva; Chesler Mark; D'Angio Giulio J; Eiser Christine; Feldges Andreas; Gibson Faith; Lackner Herwig; Masera Giuseppe; Massimo Luisa; Magyarosy Edina; Otten Jacques; Reaman Gregory; Valsecchi Maria Grazia; Veerman Anjo J P; Penn Anthony; Thorvildsen Anne; van den Bos Cor; Jankovic Momcilo;
Long term survivors of childhood cancer: cure and care. The Erice statement.
European journal of cancer (Oxford, England : 1990) 2007;43(12):1778-80.
2007: Haupt Riccardo; Jankovic Momcilo; Veerman Anjo J P;
Survivors of childhood cancer.
The New England journal of medicine 2007;356(2):192-3; author reply 193-4.
2006: Mostert Saskia; Sitaresmi Mei N; Gundy Chad M; Sutaryo; Veerman Anjo J P
Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia.
Pediatrics 2006;118(6):e1600-6.
2006: Jansen Nathalie C; Kingma Annette; Schuitema Arnout; Bouma Anke; Huisman Jaap; Veerman Anjo J; Kamps Willem A
Post-treatment intellectual functioning in children treated for acute lymphoblastic leukaemia (ALL) with chemotherapy-only: a prospective, sibling-controlled study.
European journal of cancer (Oxford, England : 1990) 2006;42(16):2765-72.
2006: Van Vlierberghe Pieter; van Grotel Martine; Beverloo H Berna; Lee Charles; Helgason Tryggvi; Buijs-Gladdines Jessica; Passier Monique; van Wering Elisabeth R; Veerman Anjo J P; Kamps Willem A; Meijerink Jules P P; Pieters Rob
The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.
Blood 2006;108(10):3520-9.
2006: van Grotel Martine; Meijerink Jules P P; Beverloo H Berna; Langerak Anton W; Buys-Gladdines Jessica G C A M; Schneider Pauline; Poulsen Tim S; den Boer Monique L; Horstmann Martin; Kamps Willem A; Veerman Anjo J P; van Wering Elisabeth R; van Noesel Max M; Pieters Rob
The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
Haematologica 2006;91(9):1212-21.
2006: Appel Inge M; den Boer Monique L; Meijerink Jules P P; Veerman Anjo J P; Reniers Nathalie C M; Pieters Rob
Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
Blood 2006;107(11):4244-9.
2006: Buizer Annemieke I; de Sonneville Leo M J; van den Heuvel-Eibrink Marry M; Veerman Anjo J P
Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumor.
Cancer 2006;106(9):2067-75.
2005: Brouwer Connie; Vogels-Mentink Trude M; Keizer-Garritsen Jenneke J; Trijbels Frans J M; Bökkerink Jos P M; Hoogerbrugge Peter M; van Wering Elisabeth R; Veerman Anjo J P; De Abreu Ronney A
Role of 5'-nucleotidase in thiopurine metabolism: enzyme kinetic profile and association with thio-GMP levels in patients with acute lymphoblastic leukemia during 6-mercaptopurine treatment.
Clinica chimica acta; international journal of clinical chemistry 2005;361(1-2):95-103.
2005: Buizer Annemieke I; De Sonneville Leo M J; van den Heuvel-Eibrink Marry M; Njiokiktjien Charles; Veerman Anjo J P
Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Journal of the International Neuropsychological Society : JINS 2005;11(5):554-65.
2005: Buizer Annemieke I; de Sonneville Leo M J; van den Heuvel-Eibrink Marry M; Veerman Anjo J P
Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
Pediatric blood & cancer 2005;45(3):281-90.
2005: Veerman A J P; Sutaryo; Sumadiono
Twinning: a rewarding scenario for development of oncology services in transitional countries.
Pediatric blood & cancer 2005;45(2):103-6.
2005: Kaspers Gertjan J L; Wijnands Jelle J M; Hartmann Reinhard; Huismans Loekie; Loonen Anne H; Stackelberg Arend; Henze Guenter; Pieters Robrecht; Hählen Karel; Van Wering Elisabeth R; Veerman Anjo J P
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
European journal of cancer (Oxford, England : 1990) 2005;41(9):1300-3.
2005: Slats A M; Egeler R M; van der Does-van den Berg A; Korbijn C; Hählen K; Kamps W A; Veerman A J P; Zwaan C M
Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(4):537-44.
2005: Brouwer Connie; De Abreu Ronney A; Keizer-Garritsen Jenneke J; Lambooy Lambert H J; Ament Kai; ter Riet Patricia G J H; van Wering Elisabeth R; Trijbels Frans J M; Veerman Anjo J P; Hoogerbrugge Peter M; Bökkerink Jos P M
Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
European journal of cancer (Oxford, England : 1990) 2005;41(4):613-23.
2005: Jansen N C; Kingma A; Tellegen P; van Dommelen R I; Bouma A; Veerman A; Kamps W A
Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: directions for future prospective research.
Archives of disease in childhood 2005;90(3):301-4.
2005: Groninger Ellis; Meeuwsen-de Boer Tiny; Koopmans Pauline; Uges Donald; Sluiter Wim; Veerman Anjo; Kamps Willem; de Graaf Siebold
Vincristine pharmacokinetics and response to vincristine monotherapy in an up-front window study of the Dutch Childhood Leukaemia Study Group (DCLSG).
European journal of cancer (Oxford, England : 1990) 2005;41(1):98-103.
2004: Hooijberg J H; Peters G J; Kaspers G J L; Wielinga P R; Veerman A J P; Pieters R; Jansen G
Online fluorescent method to assess BCRP/ABCG2 activity in suspension cells.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1451-4.
2004: Plasschaert Sabine L A; Groninger Ellis; Boezen Marike; Kema Ido; de Vries Elisabeth G E; Uges Donald; Veerman Anjo J P; Kamps Willem A; Vellenga Edo; de Graaf Siebold S; de Bont Eveline S J M
Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.
Clinical pharmacology and therapeutics 2004;76(3):220-9.
2004: Holleman Amy; Cheok Meyling H; den Boer Monique L; Yang Wenjian; Veerman Anjo J P; Kazemier Karin M; Pei Deqing; Cheng Cheng; Pui Ching-Hon; Relling Mary V; Janka-Schaub Gritta E; Pieters Rob; Evans William E
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.
The New England journal of medicine 2004;351(6):533-42.
2004: de Vries Maaike J; Veerman Anjo J P; Zwaan Christian M
Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma.
British journal of haematology 2004;125(3):414-5.
2004: Hooijberg Jan Hendrik; Jansen Gerrit; Assaraf Yehuda G; Kathmann Ietje; Pieters Rob; Laan Adrie C; Veerman Anjo J P; Kaspers Gertjan J L; Peters Godefridus J
Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1).
Biochemical pharmacology 2004;67(8):1541-8.
2004: Haarman E G; Kaspers G J L; Pieters R; Rottier M M A; Veerman A J P
Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):530-7.
2004: Ramakers-van Woerden N L; Beverloo H B; Veerman A J P; Camitta B M; Loonen A H; van Wering E R; Slater R M; Harbott J; den Boer M L; Ludwig W D; Haas O A; Janka-Schaub G E; Pieters R
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):521-9.
2003: Zwaan Christian M; Meshinchi Soheil; Radich Jerald P; Veerman Anjo J P; Huismans Dieuwke R; Munske Leonhard; Podleschny Martina; Hählen Karel; Pieters Rob; Zimmermann Martin; Reinhardt Dirk; Harbott Jochen; Creutzig Ursula; Kaspers Gertjan J L; Griesinger Frank
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.
Blood 2003;102(7):2387-94.
2003: Den Boer M L; Harms D O; Pieters R; Kazemier K M; Gobel U; Körholz D; Graubner U; Haas R J; Jorch N; Spaar H J; Kaspers G J L; Kamps W A; Van der Does-Van den Berg A; Van Wering E R; Veerman A J P; Janka-Schaub G E
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3262-8.
2003: Mavinkurve-Groothuis Annelies M C; Bokkerink Jos P M; Verweij Paul E; Veerman Anjo J P; Hoogerbrugge Peter M
Cryptococcal meningitis in a child with acute lymphoblastic leukemia.
The Pediatric infectious disease journal 2003;22(6):576.
2003: Haarman Eric G; Kaspers Gert-Jan L; Veerman Anjo J P
Glucocorticoid resistance in childhood leukaemia: mechanisms and modulation.
British journal of haematology 2003;120(6):919-29.
2003: Hooijberg Jan Hendrik; Peters Godefridus J; Assaraf Yehuda G; Kathmann Ietje; Priest David G; Bunni Marlene A; Veerman Anjo J P; Scheffer George L; Kaspers Gertjan J L; Jansen Gerrit
The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis.
Biochemical pharmacology 2003;65(5):765-71.
2003: Kaaijk P; Kaspers G J L; Van Wering E R; Broekema G J; Loonen A H; Hählen K; Schmiegelow K; Janka-Schaub G E; Henze G; Creutzig U; Veerman A J P
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.
British journal of cancer 2003;88(5):775-81.
2003: Plasschaert Sabine L A; Vellenga Edo; de Bont Eveline S J M; van der Kolk Dorina M; Veerman Anjo J P; Sluiter Wim J; Daenen Simon M G; de Vries Elisabeth G E; Kamps Willem A
High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children.
Leukemia & lymphoma 2003;44(1):85-95.
2003: Kearns Pamela R; Chrzanowska-Lightowlers Zofia M A; Pieters Rob; Veerman Anjo; Hall Andrew G
Mu class glutathione S-transferase mRNA isoform expression in acute lymphoblastic leukaemia.
British journal of haematology 2003;120(1):80-8.
2003: Bresters D; Zwaan C M; Veerman A J P; Leemans C R; Westerveld G J; van der Linden J C
A three-year-old girl with a yolk sac tumor in the orbit/maxillary sinus.
Medical and pediatric oncology 2003;40(1):70-1.
2003: Kaspers G J L; Veerman A J P
Clinical significance of cellular drug resistance in childhood leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2003;161():196-220.
2002: Zwaan Christian M; Kaspers Gertjan J L; Pieters Rob; Hählen Karel; Huismans Dieuwke R; Zimmermann Martin; Harbott Jochen; Slater Rosalyn M; Creutzig Ursala; Veerman Anjo J P
Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.
Blood 2002;100(9):3352-60.
2002: Haarman E G; Kaspers G J L; Pieters R; Rottier M M A; Den Boer M L; Janka-Schaub G E; Veerman A J P
In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37 degrees C, but not with affinity determined at room temperature.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1882-4.
2002: Groninger Ellis; Meeuwsen-de Boar Tiny; Koopmans Pauline; Uges Donald; Sluiter Wim; Veerman Anjo; Kamps Willem; de Graaf Siebold
Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia.
Pediatric research 2002;52(1):113-8.
2002: Schouten van Meeteren A Y N; van der Valk P; van der Linden H C; van Ouwerkerk W J R; Broekhuizen A J F; Huismans D R; Loonen A H; Veerman A J P
Features of proliferation and in vitro drug resistance in central primitive neuro-ectodermal tumours.
Neuropathology and applied neurobiology 2002;28(3):200-9.
2002: Kamps W A; Bökkerink J P M; Hakvoort-Cammel F G A J; Veerman A J P; Weening R S; van Wering E R; van Weerden J F; Hermans J; Slater R; van den Berg E; Kroes W G; van der Does-van den Berg A
BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(6):1099-111.
2002: Bresters Dorine; Reus Angelino C W; Veerman Anjo J P; van Wering Elizabeth R; van der Does-van den Berg Anna; Kaspers Gertjan J L
Congenital leukaemia: the Dutch experience and review of the literature.
British journal of haematology 2002;117(3):513-24.
2002: Schouten-Van Meeteren A Y N; Moll A C; Imhof S M; Veerman A J P
Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.
Medical and pediatric oncology 2002;38(6):428-38.
2002: Ramakers-van Woerden N L; Pieters R; Hoelzer D; Slater R M; den Boer M L; Loonen A H; Harbott J; Janka-Schaub G E; Ludwig W-D; Ossenkoppele G J; van Wering E R; Veerman A J P;
In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.
Medical and pediatric oncology 2002;38(6):379-86.
2002: Ramakers-van Woerden N L; Pieters R; Rots M G; van Zantwijk C H; Noordhuis P; Beverloo H B; Peters G J; van Wering E R; Camitta B M; Pui C-H; Relling M V; Evans W E; Veerman A J P
Infants with acute lymphoblastic leukemia: no evidence for high methotrexate resistance.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(5):949-51.
2002: Zwaan Christian M; Kaspers Gertjan J L; Pieters Rob; Hählen Karel; Janka-Schaub Gritta E; van Zantwijk Christina H; Huismans Dieuwke R; de Vries Esther; Rots Marianne G; Peters Godefridus J; Jansen Gerrit; Creutzig Ursula; Veerman Anjo J P
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Blood 2002;99(1):245-51.
2001: Schouten-van Meeteren A Y; van der Valk P; van der Linden H C; Moll A C; Imhof S M; Huismans D R; Loonen A H; Veerman A J
Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay.
Cancer 2001;92(11):2933-40.
2001: Hubeek I; Ramakers-van Woerden N L; Pieters R; Slater R; Beverloo H B; van Wering E R; Kamps W; Hählen K; Veerman A J
TEL/AML1 fusion is not a prognostic factor in Dutch childhood acute lymphoblastic leukaemia.
British journal of haematology 2001;113(1):254-5.
2001: Rots M G; Pieters R; Jansen G; Kaspers G J; Van Zantwijk C H; Noordhuis P; Voorn D A; Van Wering E R; Creutzig U; Veerman A J; Peters G J
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemia.
European journal of cancer (Oxford, England : 1990) 2001;37(4):492-8.
2001: Ramakers-van Woerden N L; Pieters R; Slater R M; Loonen A H; Beverloo H B; van Drunen E; Heyman M; Moreno T C; Rots M G; van Wering E R; Kamps W A; Janka-Schaub G E; Veerman A J
In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemia.
British journal of haematology 2001;112(3):680-90.
2000: Kamps W A; Veerman A J; van Wering E R; van Weerden J F; Slater R; van der Does-van den Berg A
Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984-1991.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2240-6.
2000: Rots M G; Willey J C; Jansen G; Van Zantwijk C H; Noordhuis P; DeMuth J P; Kuiper E; Veerman A J; Pieters R; Peters G J
mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2166-75.
2000: Zwaan C M; Kaspers G J; Pieters R; Ramakers-Van Woerden N L; den Boer M L; Wünsche R; Rottier M M; Hählen K; van Wering E R; Janka-Schaub G E; Creutzig U; Veerman A J
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemia.
Blood 2000;96(8):2879-86.
2000: Styczynski J; Pieters R; Huismans D R; Schuurhuis G J; Wysocki M; Veerman A J
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;110(4):813-8.
2000: Rots M G; Pieters R; Kaspers G J; Veerman A J; Peters G J; Jansen G
Classification of ex vivo methotrexate resistance in acute lymphoblastic and myeloid leukaemia.
British journal of haematology 2000;110(4):791-800.
2000: Ramakers-van Woerden N L; Pieters R; Loonen A H; Hubeek I; van Drunen E; Beverloo H B; Slater R M; Harbott J; Seyfarth J; van Wering E R; Hählen K; Schmiegelow K; Janka-Schaub G E; Veerman A J
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
Blood 2000;96(3):1094-9.
2000: Rots M G; Pieters R; Peters G J; Noordhuis P; Van Zantwijk C H; Henze G; Janka-Schaub G E; Veerman A J; Jansen G
Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;109(3):629-34.
2000: Brouwer C; Keizer-Garritsen J J; Lambooy L H; Ament K; Ter Riet P G; De Abreu R A; Bökkerink J P; Van Wering E R; Van Der Does-Van Den Berg A; Veerman A J; Trijbels J P
Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemia.
Advances in experimental medicine and biology 2000;486():327-31.
1999: Den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Veerman A J
Relationship between the intracellular daunorubicin concentration, expression of major vault protein/lung resistance protein and resistance to anthracyclines in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(12):2023-30.
1999: Rots M G; Pieters R; Peters G J; van Zantwijk C H; Mauritz R; Noordhuis P; Willey J C; Hählen K; Creutzig U; Janka-Schaub G; Kaspers G J; Veerman A J; Jansen G
Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolates.
Blood 1999;94(9):3121-8.
1999: Mui D; Pieters R; Veerman A J
[Blood platelets in children too few and too large: the giant platelet syndromes]
Nederlands tijdschrift voor geneeskunde 1999;143(38):1918-22.
1999: Kaspers G J; Zwaan C M; Veerman A J; Rots M G; Pieters R; Bucsky P; Domula M; Göbel U; Graf N; Havers W; Jorch N; Kabisch K; Spaar H J; Ritter J; Creutzig U
Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study.
Klinische Pädiatrie 1999;211(4):239-44.
1999: Den Boer M L; Kapaun P; Pieters R; Kazemier K M; Janka-Schaub G E; Veerman A J
Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.
British journal of haematology 1999;105(4):876-82.
1999: Duyn A E; Kaspers G J; Pieters R; Van Zantwijk C H; Broekema G J; Hählen K; Veerman A J
Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia.
Annals of hematology 1999;78(4):163-71.
1999: Rots M G; Pieters R; Peters G J; Noordhuis P; van Zantwijk C H; Kaspers G J; Hählen K; Creutzig U; Veerman A J; Jansen G
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
Blood 1999;93(5):1677-83.
1999: Den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Creutzig U; Kaspers G J; Kearns P R; Hall A G; Pearson A D; Veerman A J
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia.
British journal of haematology 1999;104(2):321-7.
1999: Rots M G; Pieters R; Kaspers G J; van Zantwijk C H; Noordhuis P; Mauritz R; Veerman A J; Jansen G; Peters G J
Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
Blood 1999;93(3):1067-74.
1999: Hegge I R; Kaspers G J; Rots M G; Jansen G; Pieters R; Veerman A J
Lack of cross-resistance between prednisolone and methotrexate in childhood acute lymphoblastic leukemia? A preliminary analysis.
Advances in experimental medicine and biology 1999;457():551-5.
1999: Kaspers G J; Zwaan C M; Pieters R; Veerman A J
Cellular drug resistance in childhood acute myeloid leukemia. A mini-review with emphasis on cell culture assays.
Advances in experimental medicine and biology 1999;457():415-21.
1999: Pieters R; Kaspers G J; Ramakers-van Woerden N L; den Boer M L; Rots M G; Zwaan C M; Haarman E G; Veerman A J
Resistance testing and mechanisms of resistance in childhood leukemia. Studies from Amsterdam.
Advances in experimental medicine and biology 1999;457():391-5.
1999: Haarman E G; Kaspers G J; Pieters R; van Zantwijk C H; Broekema G J; Hählen K; Veerman A J
BCL-2 expression in childhood leukemia versus spontaneous apoptosis, drug induced apoptosis, and in vitro drug resistance.
Advances in experimental medicine and biology 1999;457():325-33.
1999: Kearns P; Pieters R; Rottier M M; Veerman A J; Schmiegalow K; Pearson A D; Hall A G
Glutathione in childhood acute leukaemias.
Advances in experimental medicine and biology 1999;457():211-6.
1998: Den Boer M L; Pieters R; Veerman A J
Mechanisms of cellular anthracycline resistance in childhood acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(11):1657-70.
1998: Mauritz R; Bekkenk M W; Rots M G; Pieters R; Mini E; van Zantwijk C H; Veerman A J; Peters G J; Jansen G
Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(10):2399-410.
1998: Pieters R; den Boer M L; Durian M; Janka G; Schmiegelow K; Kaspers G J; van Wering E R; Veerman A J
Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia--implications for treatment of infants.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(9):1344-8.
1998: Kaspers G J; Pieters R; Van Zantwijk C H; Van Wering E R; Van Der Does-Van Den Berg A; Veerman A J
Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
Blood 1998;92(1):259-66.
1998: den Boer M L; Pieters R; Kazemier K M; Janka-Schaub G E; Henze G; Veerman A J
The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(6):912-20.
1998: den Boer M L; Pieters R; Kazemier K M; Rottier M M; Zwaan C M; Kaspers G J; Janka-Schaub G; Henze G; Creutzig U; Scheper R J; Veerman A J
Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
Blood 1998;91(6):2092-8.
1997: Kaspers G J; Veerman A J; Pieters R; Van Zantwijk C H; Smets L A; Van Wering E R; Van Der Does-Van Den Berg A
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.
Blood 1997;90(7):2723-9.
1997: Den Boer M L; Zwaan C M; Pieters R; Kazemier K M; Rottier M M; Flens M J; Scheper R J; Veerman A J
Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11(7):1078-85.
1997: Neuendank A; Hartmann R; Bührer C; Winterhalter B; Klumper E; Veerman A J; Henze G
Acute toxicity and effectiveness of idarubicin in childhood acute lymphoblastic leukemia.
European journal of haematology 1997;58(5):326-32.
1997: Pieters R; Klumper E; Kaspers G J; Veerman A J
Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia.
Critical reviews in oncology/hematology 1997;25(1):11-26.
1996: Kaspers G J; Veerman A J; Popp-Snijders C; Lomecky M; Van Zantwijk C H; Swinkels L M; Van Wering E R; Pieters R
Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.
Medical and pediatric oncology 1996;27(2):114-21.
1996: Klumper E; Ossenkoppele G J; Pieters R; Huismans D R; Loonen A H; Rottier A; Westra G; Veerman A J
In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.
British journal of haematology 1996;93(4):903-10.
1996: Kaspers G J; Veerman A J; Van Wering E R; Van Der Linden-Schrever B E; Van Zantwijk C H; Van Der Does-Van Den Berg A; Pieters R
Prognostic significance of peanut agglutinin binding in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(4):675-81.
1996: Kardos G; Veerman A J; de Waal F C; van Oudheusden L J; Slater R
Familial sideroblastic anemia with emergence of monosomy 5 and myelodysplastic syndrome.
Medical and pediatric oncology 1996;26(1):54-6.
1995: Kaspers G J; Pieters R; Van Zantwijk C H; Van Wering E R; Veerman A J
Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells.
Leukemia & lymphoma 1995;19(5-6):407-16.
1995: Klumper E; Pieters R; Veerman A J; Huismans D R; Loonen A H; Hählen K; Kaspers G J; van Wering E R; Hartmann R; Henze G
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.
Blood 1995;86(10):3861-8.
1995: Klumper E; Giaccone G; Pieters R; Broekema G; van Ark-Otte J; van Wering E R; Kaspers G J; Veerman A J
Topoisomerase II alpha gene expression in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1995;9(10):1653-60.
1995: Klumper E; Pieters R; den Boer M L; Huismans D R; Loonen A H; Veerman A J
In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.
British journal of cancer 1995;71(6):1188-93.
1995: Kaspers G J; Veerman A J; Pieters R; Van Zantwijk I; Hählen K; Van Wering E R
Drug combination testing in acute lymphoblastic leukemia using the MTT assay.
Leukemia research 1995;19(3):175-81.
1995: Kaspers G J; Smets L A; Pieters R; Van Zantwijk C H; Van Wering E R; Veerman A J
Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study.
Blood 1995;85(3):751-6.
1994: Kaspers G J; Veerman A J; Pieters R; Broekema G J; Huismans D R; Kazemier K M; Loonen A H; Rottier M A; van Zantwijk C H; Hählen K
Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.
British journal of cancer 1994;70(6):1047-52.
1994: Kaspers G J; Kardos G; Pieters R; Van Zantwijk C H; Klumper E; Hählen K; de Waal F C; van Wering E R; Veerman A J
Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(7):1224-9.
1994: Pieters R; Kaspers G J; Klumper E; van Wering E R; van der Does-van den Berg A; Veerman A J
[Clinical relevance of resistance against cytostatic agents in children with leukemia]
Nederlands tijdschrift voor geneeskunde 1994;138(14):706-12.
1994: Kaspers G J; Pieters R; Klumper E; De Waal F C; Veerman A J
Glucocorticoid resistance in childhood leukemia.
Leukemia & lymphoma 1994;13(3-4):187-201.
1994: Kaspers G L; Veerman A J; Pieters R; van Zantwijk I; Klumper E; Hählen K; de Waal F C; van Wering E R
In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(1):24-9.
1994: Pieters R; Kaspers G J; Klumper E; Veerman A J
Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.
Medical and pediatric oncology 1994;22(5):299-308.
1994: Veerman A J; Kaspers G J; Pieters R
Cellular drug resistance in childhood leukemia.
Annals of hematology 1994;69 Suppl 1():S31-4.
1994: van Oostveen D C; Pieters R; Peters G J; Veerman A J
Purine nucleotide interconversion enzymes in childhood leukemia: relation with cell cycle and clinical outcome.
Advances in experimental medicine and biology 1994;370():209-12.
1993: Pieters R; Kaspers G J; van Wering E R; Huismans D R; Loonen A H; Hählen K; Veerman A J
Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(3):392-7.
1993: Kaspers G J; Pieters R; Klumper E; de Waal F C; Veerman A J
[The treatment of recurrence in children with acute lymphatic leukemia. Current results and various developments]
Tijdschrift voor kindergeneeskunde 1993;61(1):1-7.
1993: Pieters R; Kaspers G J; van Wering E R; Huismans D R; Loonen A H; Hählen K; Veerman A J
Cellular drug sensitivity of immunophenotypic subgroups of childhood acute lymphoblastic leukemia.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;131():249-56.
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
Leukemia research 1992;16(9):873-80.
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Adenosine deaminase and purine nucleoside phosphorylase in childhood lymphoblastic leukemia: relation with differentiation stage, in vitro drug resistance and clinical prognosis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(5):375-80.
1992: Pieters R; Huismans D R; Loonen A H; Peters G J; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Hypoxanthine-guanine phosphoribosyl-transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis.
International journal of cancer. Journal international du cancer 1992;51(2):213-7.
1992: Pieters R; Hongo T; Loonen A H; Huismans D R; Broxterman H J; Hählen K; Veerman A J
Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
British journal of cancer 1992;65(5):691-7.
1991: Pieters R; Huismans D R; Loonen A H; Hählen K; Veerman A J
Cytotoxic effects of vitamin A in combination with vincristine, daunorubicin and 6-thioguanine upon cells from lymphoblastic leukemic patients.
Japanese journal of cancer research : Gann 1991;82(9):1051-5.
1991: Kaspers G J; Pieters R; Van Zantwijk C H; De Laat P A; De Waal F C; Van Wering E R; Veerman A J
In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood.
British journal of cancer 1991;64(3):469-74.
1991: Kaspers G J; Kamphorst W; van de Graaff M; van Alphen H A; Veerman A J
Primary spinal epidural extraosseous Ewing's sarcoma.
Cancer 1991;68(3):648-54.
1991: Pieters R; Huismans D R; Loonen A H; Hählen K; van der Does-van den Berg A; van Wering E R; Veerman A J
Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.
Lancet 1991;338(8764):399-403.
1991: Pieters R; Thompson L F; Broekema G J; Huismans D R; Peters G J; Pals S T; Horst E; Hählen K; Veerman A J
Expression of 5'-nucleotidase (CD73) related to other differentiation antigens in leukemias of B-cell lineage.
Blood 1991;78(2):488-92.
1990: Pieters R; Loonen A H; Huismans D R; Broekema G J; Dirven M W; Heyenbrok M W; Hählen K; Veerman A J
In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.
Blood 1990;76(11):2327-36.
1990: Haraldsson A; Veerman A J; Weemaes C M
[Cat-scratch disease]
Tijdschrift voor kindergeneeskunde 1990;58(6):200-3.
1990: Veerman A J; Pieters R
Drug sensitivity assays in leukaemia and lymphoma.
British journal of haematology 1990;74(4):381-4.
1989: Pieters R; Taets van Amerongen A H; van Brenk A I; Veerman A J
[Bone necrosis as a sequela of chemotherapy in hematologically malignant disorders]
Nederlands tijdschrift voor geneeskunde 1989;133(43):2117-22.
1989: Pieters R; van der Schans-Dop A M; van Brenk A I; Taets van Amerongen A H; Veerman A J
Osteonecrosis following chemotherapy for leukemia.
European journal of haematology 1989;43(3):262-4.
1989: Pieters R; Huismans D R; Leyva A; Veerman A J
Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
British journal of cancer 1989;59(2):217-20.
1989: Pieters R; Huismans D R; Leyva A; Veerman A J
Sensitivity to purine analogues in childhood leukemia assessed by the automated MTT-assay.
Advances in experimental medicine and biology 1989;253A():447-54.
1988: Pieters R; Veerman A J
The role of 5'nucleotidase in therapy-resistance of childhood leukemia.
Medical hypotheses 1988;27(1):77-80.
1988: Pieters R; Huismans D R; Leyva A; Veerman A J
Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia.
Cancer letters 1988;41(3):323-32.
1988: van den Doel L J; Pieters R; Huismans D R; van Zantwijk C H; Loonen A H; Broekema G J; de Waal F C; Veerman A J
Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia.
European journal of haematology 1988;41(2):170-5.
1988: de Waal F C; Huisman J; Veerman A J
[Sedation and analgesia in interventions]
Tijdschrift voor kindergeneeskunde 1988;56(2):82-5.
1988: van Wering E R; Veerman A J; van der Linden-Schrever B E
Diagnosis of meningeal involvement in childhood acute lymphoblastic leukemia: cytomorphology and TdT.
European journal of haematology 1988;40(3):250-5.
1988: van Zanten T E; Golding R P; Taets van Amerongen A H; Pieters R; Veerman A J
Nuclear magnetic resonance imaging of bone marrow in childhood leukaemia.
Clinical radiology 1988;39(1):77-81.
1987: Pieters R; van Brenk A I; Veerman A J; van Amerongen A H; van Zanten T E; Golding R P
Bone marrow magnetic resonance studies in childhood leukemia. Evaluation of osteonecrosis.
Cancer 1987;60(12):2994-3000.
1987: Pieters R; van Brenk A I; Veerman A J; Taets van Amerongen A H; van Zanten T E; Golding R P
[Electron spin resonance tomography of the musculoskeletal system]
Nederlands tijdschrift voor geneeskunde 1987;131(36):1586.
1987: Pieters R; Veerman A J
Prognostic significance of acid alpha-naphthyl acetate esterase and acid phosphatase in childhood acute lymphoblastic leukemia.
Leukemia research 1987;11(11):995-9.
1987: Hogeman P H; Veerman A J; Huismans D R; Van Zantwijk C H; Bezemer P D
Motility of leukemic cells in collagen gel related to immunological phenotype in childhood acute lymphoblastic leukemia.
Acta haematologica 1987;78(4):229-32.
1986: Hogeman P H; Veerman A J; Huismans D R; van Zantwijk C H; Bezemer P D
Capping of leukemic cells with monoclonal anti-HLA-A,B,C related to prognosis in childhood acute lymphoblastic leukemia.
Acta haematologica 1986;76(2-3):119-23.
1985: Hogeman P H; Veerman A J; Huismans D R; Van Zantwijk I H
Common acute lymphoblastic leukemia antigen-positive cells in normal bone marrow.
Blood 1985;66(1):246-7.
1985: Veerman A J; Hogeman P H; Huismans D R; Van Zantwijk C H; Bezemer P D
Peanut agglutinin, a marker for T-cell acute lymphoblastic leukemia with a good prognosis.
Cancer research 1985;45(4):1890-3.
1985: Hogeman P H; Veerman A J; Van Zantwijk C H; Huismans D R
Peanut agglutinin distinguishes CALLA positive reactive bone marrow cells from leukaemic blasts.
British journal of haematology 1985;59(2):392-4.
1985: Hogeman P H; Veerman A J; de Waal F C; Bezemer P D; Huismans D R; van Zantwijk C H
Handmirror cells in childhood acute lymphoblastic leukemia related to immunological phenotype.
The American journal of pediatric hematology/oncology 1985;7(3):217-20.
1985: Veerman A J; Hogeman P H; van Zantwijk C H; Bezemer P D
Prognostic value of 5'nucleotidase in acute lymphoblastic leukemia with the common-ALL phenotype.
Leukemia research 1985;9(10):1227-9.
1985: Hogeman P H; Veerman A J; Philippus E; Huismans D R; van Zantwijk C H; Bezemer P D
Significance of number of HLA determinants in HLA capping in childhood acute lymphoblastic leukemia.
Acta haematologica 1985;73(4):196-200.
1984: Veerman A J; Huismans D R; van Zantwijk C H; de Waal F C
[Immunologic determination of surface determinants on cells in the cerebrospinal fluid of children with acute lymphatic leukemia]
Nederlands tijdschrift voor geneeskunde 1984;128(3):100-3.
1984: Hogeman P H; Veerman A J; Huismans D R; Van Zantwijk C; Bezemer P D; Stamhuis I H; De Waal F C
Handmirror cells and central nervous system relapse in childhood acute lymphoblastic leukaemia.
Acta haematologica 1984;72(3):181-9.
1984: Hogeman P H; Veerman A J; Huismans D R; Bezemer P D
Differences in capping behavior between immunological phenotypes in childhood acute lymphoblastic leukemia. A study with ConA and an anti-HLA-ABC backbone.
Acta haematologica 1984;72(1):7-13.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Anjo Veerman

Research Profile (preview)

Disorders

Physiology

Chemicals & Drugs

Living Beings

Anatomy

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Anjo Veerman (preview)

All Publications